Literature DB >> 23358854

Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β.

Yazan Hassona1, Nicola Cirillo, Kue Peng Lim, Andrew Herman, Max Mellone, Gareth J Thomas, Gayani N Pitiyage, E Ken Parkinson, Stephen S Prime.   

Abstract

Keratinocyte senescence acts as a barrier to tumor progression but appears to be lost in late pre-malignancy to yield genetically unstable oral squamous cell carcinomas (GU-OSCC); a subset of OSCC possessing wild-type p53 and are genetically stable (GS-OSCC). In this study, fibroblasts from GU-OSCC were senescent relative to fibroblasts from GS-OSCC, epithelial dysplastic tissues or normal oral mucosa, as demonstrated by increased senescence-associated β-galactosidase (SA β-Gal) activity and overexpression of p16(INK4A). Keratinocytes from GU-OSCC produced high levels of reactive oxygen species (ROS) and this was associated with an increase in the production of transforming growth factor-β1 (TGF-β1) and TGF-β2 in stromal fibroblasts. Treatment of normal fibroblasts with keratinocyte conditioned media (CM) from GU-OSCC, but not GS-OSCC or dysplastic keratinocytes with dysfunctional p53, induced fibroblast senescence. This phenomenon was inhibited by antioxidants and anti-TGF-β antibodies. Fibroblast activation by TGF-β1 preceded cellular senescence and was associated with increased ROS levels; antioxidants inhibited this reaction. Senescent fibroblasts derived from GU-OSCC or normal fibroblasts treated with CM from GU-OSCC or hydrogen peroxide, but not non-senescent fibroblasts derived from GS-OSCC, promoted invasion of keratinocytes in vitro. Epithelial invasion was stimulated by fibroblast activation and amplified further by fibroblast senescence. The data demonstrate that malignant keratinocytes from GU-OSCC, but not their pre-malignant counterparts, produce high levels of ROS, which, in turn, increase TGF-β1 expression and induce fibroblast activation and senescence in a p5-independent manner. Fibroblasts from GU-OSCC were particularly susceptible to oxidative DNA damage because of high levels of ROS production, downregulation of antioxidant genes and upregulation of pro-oxidant genes. The results demonstrate the functional diversity of cancer-associated fibroblasts and show that malignant keratinocytes from GU-OSCC reinforce their malignant behavior by inducing fibroblast activation and senescence through ROS and TGF-β-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358854     DOI: 10.1093/carcin/bgt035

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  32 in total

Review 1.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

2.  Correlation of TGF-β1 and oxidative stress in the blood of patients with melanoma: a clue to understanding melanoma progression?

Authors:  Sara Santos Bernardes; Fernando Pinheiro de Souza-Neto; Gabriella Pasqual Melo; Flávia Alessandra Guarnier; Poliana Camila Marinello; Rubens Cecchini; Alessandra L Cecchini
Journal:  Tumour Biol       Date:  2016-02-12

3.  Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma associated fibroblasts.

Authors:  Zhuoyuan Zhang; Zhenjie Gao; Saroj Rajthala; Dipak Sapkota; Harsh Dongre; Himalaya Parajuli; Salwa Suliman; Ridhima Das; Longjiang Li; Laurence A Bindoff; Daniela Elena Costea; Xiao Liang
Journal:  Cell Mol Life Sci       Date:  2019-07-03       Impact factor: 9.261

4.  Effect of ALA-PDT on inhibition of oral precancerous cell growth and its related mechanisms.

Authors:  Jian-Qiu Jin; Qian Wang; Yu-Xing Zhang; Xing Wang; Zhi-Yue Lu; Bo-Wen Li
Journal:  Lasers Med Sci       Date:  2022-07-07       Impact factor: 3.161

Review 5.  The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer.

Authors:  Justyna Mikuła-Pietrasik; Szymon Rutecki; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2022-03-19       Impact factor: 9.261

6.  Extracellular Prostaglandins E1 and E2 and Inflammatory Cytokines Are Regulated by the Senescence Program in Potentially Premalignant Oral Keratinocytes.

Authors:  Lee Peng Karen-Ng; Usama Sharif Ahmad; Luis Gomes; Keith David Hunter; Hong Wan; Eleni Hagi-Pavli; Eric Kenneth Parkinson
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

Review 7.  Selenoproteins in Tumorigenesis and Cancer Progression.

Authors:  Sarah P Short; Christopher S Williams
Journal:  Adv Cancer Res       Date:  2017       Impact factor: 6.242

8.  MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence.

Authors:  Marta Gabasa; Evette S Radisky; Rafael Ikemori; Giulia Bertolini; Marselina Arshakyan; Alexandra Hockla; Paula Duch; Ornella Rondinone; Alejandro Llorente; Maria Maqueda; Albert Davalos; Elena Gavilán; Alexandre Perera; Josep Ramírez; Pere Gascón; Noemí Reguart; Luca Roz; Derek C Radisky; Jordi Alcaraz
Journal:  Cancer Lett       Date:  2021-03-06       Impact factor: 9.756

9.  (6E,10E) Isopolycerasoidol and (6E,10E) Isopolycerasoidol Methyl Ester, Prenylated Benzopyran Derivatives from Pseuduvaria monticola Induce Mitochondrial-Mediated Apoptosis in Human Breast Adenocarcinoma Cells.

Authors:  Hairin Taha; Chung Yeng Looi; Aditya Arya; Won Fen Wong; Lee Fah Yap; Mohadeseh Hasanpourghadi; Mustafa A Mohd; Ian C Paterson; Hapipah Mohd Ali
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

10.  Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion.

Authors:  Y Hassona; N Cirillo; K Heesom; E K Parkinson; S S Prime
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.